July 26, 2022
Third and fourth COVID-19 vaccine doses provided significant protection to healthy adults who were eligible to receive them as the Omicron variant spread during early 2022.
In a new Morbidity and Mortality Weekly Report, the agency evaluated the effectiveness of the COVID-19 vaccines through hundreds of thousands of emergency department/urgent care visits, as well as 58,000 hospitalizations from 10 states from mid-December 2021 through mid-June 2022.
“COVID-19 vaccines remain our single most important tool to protect people against serious illness, hospitalization, and death,” the CDC said in a statement.
Among the key takeaways:
The report also noted that when BA.1 was the predominant variant, vaccine effectiveness was 61 percent for two doses against COVID-19-associated hospitalizations compared to 85–92 percent after a third dose.
HAP encourages everyone to stay up to date on their COVID-19 vaccines to support the safety and health our communities. Learn more about the available options in your area.
The full report is available to review online.
Tags: Public Health | COVID-19
Click on topic below for category-specific news articles.
Support a healthier Pennsylvania.